A case of concomitant leukemoid reaction and mucormycosis in a patient with severe COVID-19 infection

Sayed Issa Rand; Mushtaq Gohar; Unnisa Aziz; Mahli Abdo

doi:10.1515/tjb-2023-0016

Türk Biyokimya Dergisi (Jul 2023)

A case of concomitant leukemoid reaction and mucormycosis in a patient with severe COVID-19 infection

Sayed Issa Rand,
Mushtaq Gohar,
Unnisa Aziz,
Mahli Abdo

Affiliations

Sayed Issa Rand: Department of Pharmaceutics, Faculty of Pharmacy, Idlib University, Idlib, Syria
Mushtaq Gohar: Center for Scientific Research, Faculty of Medicine, Idlib University, Idlib, Syria
Unnisa Aziz: Department of Pharmaceutical Chemistry, College of Pharmacy, University of Hail, Hail, Saudi Arabia
Mahli Abdo: Department of Pharmacology and Biomedical Sciences, Faculty of Pharmacy and Medical Sciences, University of Petra, Amman, Jordan

DOI: https://doi.org/10.1515/tjb-2023-0016
Journal volume & issue: Vol. 48, no. 4
pp. 446 – 450

Abstract

Read online

Leukemoid Reaction (LR) signifies leukocytosis characterized by mature neutrophils. The incidence of LR is about 1 % among hospitalized patients. Mucormycosis is a rare, aggressive, fatal fungal infection that afflicts immune-compromised patients. This study discusses the case of concomitant leukemoid reaction and mucormycosis in a patient with severe COVID-19 infection.

Published in Türk Biyokimya Dergisi

ISSN: 1303-829X (Online)
Publisher: De Gruyter
Country of publisher: Germany
LCC subjects: Science: Chemistry: Organic chemistry: Biochemistry
Website: https://www.degruyter.com/journal/key/tjb/html

About the journal

Abstract

Keywords